Evaluating Adjunctive Cryopreserved Amniotic Membrane Treatment in Herpes Simplex Dendritic Keratitis

Inclusion Criteria: 1. The subject (male or female) is at least 18 years of age. 2. The subject is presenting with primary or recurrent herpetic dendritic epithelial keratitis based on investigator judgement 3. The subject is presenting with acute (within 30 days) herpetic dendritic epithelial keratitis 4. The subject is willing to comply with all study procedures and is able to consent. Exclusion Criteria: 1. Clinical signs of a cause other than herpes simplex virus 2. Presence of corneal ulcer with or without microbial infection 3. Lid surface abnormalities or conjunctival scarring that affect lid function in either eye 4. Atopic disease 5. History of penetrating keratoplasty 6. Active stromal keratitis or iritis 7. Presence of systemic or ocular infection or inflammation that is not related to herpes simplex virus (such as Sarcoidosis, Cogan syndrome, atopy, Lyme disease, Syphilis, mumps, Epstein-Barr virus) 8. Ocular surface malignancy 9. History of recent ocular surgery/trauma, which could affect corneal sensitivity, e.g., corneal transplantation, LASIK 10. A medical or ocular condition, or a personal situation, which in the principal investigator's opinion, is not appropriate for participation in the trial 11. Current enrollment in another interventional drug or device study or participation in such a study within 30 days of anticipated entry into this study 12. Not capable of providing informed consent